Home | Blog | General health | Weight Loss | Can you switch from weight loss injections to pills?
If you’re currently using a weight loss injection or are looking to restart treatment with one, you might be considering switching to a weight loss pill. In this guide, we’ll look at who can switch from weight loss injections to pills, and how to do it safely.

Most people who are using a weight loss injection should be able to switch to weight loss pills.
Before starting any new weight loss medication, you’ll first need to meet certain medical criteria. Having a BMI of 30 or over, or of 27 or above if you have a weight-related condition, like diabetes, are two such criteria.
But if you’ve been using a weight loss injection for a while, your BMI might have dropped below this. If this is the case, your clinician might look at your starting weight before you begin treatment, to see if they think switching to weight loss pills is the best option for you.
If you’re maintaining a healthy weight while using a weight loss injection, your clinician might discuss why you want to switch to using weight loss pills. And before they recommend any options, they’ll talk about your diet, activity levels, and your weight loss targets.
They’ll also look at your medical history, including existing medications you take that might cause interactions when combined with weight loss pills. They’ll also consider whether or not it’s safe for you to fast for specific periods of time, which weight loss pills (like oral Wegovy) require you to do.
If your clinician is happy for you to start using them, they’ll help you develop a plan to switch from injections to pills.
So what are the main reasons people make the switch?
Convenience
For some people, self-administering injections can be daunting. Even if you’ve gotten used to injecting yourself when using a GLP-1 pen, it might still feel painful to do and can sometimes cause bruising.
Switching to a weight loss pill completely removes any needle phobias or doubts about how to correctly use your treatment. Swallowing a tablet each day can be easily incorporated into your daily routine, and might make your dosage schedule feel simpler too.
Travel and storage
All GLP-1 injections, such as Wegovy, are stored between 2°C and 8°C. This means they need to be kept in the fridge at all times at home, and often need to be packed into gel ice packs to stay cool when delivered to you.
Storing injections in the fridge at home might be easy enough, but they can sometimes take up valuable space. If you’re in rented or shared accommodation, you may feel like you don’t want them to be visible for other people to see.
Because weight loss pills are stored at room temperature, you can keep them virtually anywhere. There’s a much lower risk of spoilage, and they’re a much simpler option for travelling as you don’t need to worry about keeping them chilled.
Less fluctuations
When you’re using a weekly weight loss injection like Wegovy, you typically experience a spike of the medication in your system in the first few days after taking your dose. But towards the back end of the week, when your next injection is almost due, it’s normal for those levels to dip.
This fluctuation can make it harder to regulate your appetite consistently, and might mean that you feel like the medication is wearing off. Because you take tablets like the Wegovy pill daily, there should be a more even level of semaglutide in your bloodstream, which can mean you’re less likely to experience hunger and ‘food noise’ between doses.
How effective weight loss pills are will vary widely person-to-person. This is because weight loss doesn’t tend to follow a linear path, which means there’s no standard treatment or dose schedule that guarantees results.
Until recently, GLP-1 injections like Mounjaro and Wegovy were considered far more effective for average weight loss when compared to weight loss tablets such as Orlistat.
In one 68 week study of patients using a 2.4mg dose of weekly semaglutide, it was shown to help them lose 14.9% of their starting weight. In a different study, which looked at the effectiveness of Orlistat, patients lost just 8.5% of their initial weight after using when using it daily for a year.
But the recent higher doses of weight loss tablets like the Wegovy pill have significantly bridged the gap between the effectiveness of injections versus pills. In one 71 week study, the 25mg maintenance dose Wegovy pill helped patients achieve an average of 16.9% weight loss after 64 weeks.
Your clinician will help you switch from using a GLP-1 injection to taking a weight loss pill instead.
You’ll usually be advised to wait until half of the medication you’re currently taking has left your system, but this often differs between medications. For medications like Saxenda, this might be achieved in a few days, but weekly weight loss injections like Mounjaro and Wegovy tend to have a longer half-life.
Whichever injection you’re using, your clinician will tailor a switching plan to your needs, and decide which dose you should start on once you begin using weight loss pills.
Yes, you will need a new prescription when you start using weight loss pills.
If you do decide to switch from weight loss injections, you’ll be starting a whole new treatment plan altogether. Even though the active ingredients in both your old medication and your new one might be the same (if you switched from Wegovy injections to pills for example), the formulation you use and your dosage schedule will be completely different. So it might be helpful to think of it as a different treatment altogether, which requires a fresh prescription.
Comparative Effectiveness of Semaglutide, Liraglutide, Orlistat, and Phentermine for Weight Loss in Obese Individuals: A Systematic Review. Cureus.
Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), pp.989–1002.
One-year treatment of obesity: a randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor. International Journal of Obesity, 24(3), pp.306–313.
Oral Semaglutide at a Dose of 25 mg in Adults with Overweight or Obesity. New England Journal of Medicine, 393(11), pp.1077–1087.
How we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.
Have a subject you’d like us to cover in a future article? Let us know.
We're making healthcare more about you. Sign up to our newsletter for personalised health articles that make a difference.
Disclaimer: The information provided on this page is not a substitute for professional medical advice, diagnosis, or treatment. If you have any questions or concerns about your health, please talk to a doctor.
We couldn't find what you're looking for.
Here's everything we treat. Or, if you're looking for something we don't have yet, you can suggest something.
By clicking 'Subscribe now' you're agreeing to our Privacy Policy.
(And leave your email too, so we can let you know if we write an article based on your suggestion.)
Last updated on Aug 7, 2026.
Our experts continually monitor new findings in health and medicine, and we update our articles when new info becomes available.
Aug 07, 2026
Published by: The Treated Content Team. Medically reviewed by: Ms Sanjeda Chowdhury, Superintendent Pharmacist + Independent PrescriberHow we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.
Superintendent Pharmacist + Independent Prescriber
Sanjeda runs our pharmacy, based in Bolton. She works closely with our doctors and prescribers, ensuring that the treatments we recommend are safe, and that all medicines are dispensed correctly. Sanjeda is also an Independent Prescriber. Registered with GPhC (No. 2202465)
MeetHow we source info.
When we present you with stats, data, opinion or a consensus, we’ll tell you where this came from. And we’ll only present data as clinically reliable if it’s come from a reputable source, such as a state or government-funded health body, a peer-reviewed medical journal, or a recognised analytics or data body. Read more in our editorial policy.